- Filed
- Jan 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jan 10, 2024 | 53.2M sh |
| Short Term Investments | Q1 2024 · Nov 30, 2023 | $5.3M |
| Short Term Investments | Q1 2024 · Aug 31, 2023 | $5.5M |
| Cash And Equivalents | Q1 2024 · Nov 30, 2023 | $135.02K |
| Cash And Equivalents | Q1 2024 · Aug 31, 2023 | $492.61K |
| Current Liabilities | Q1 2024 · Nov 30, 2023 | $331.57K |
| Current Liabilities | Q1 2024 · Aug 31, 2023 | $287.23K |
| Total Liabilities | Q1 2024 · Nov 30, 2023 | $331.57K |
| Total Liabilities | Q1 2024 · Aug 31, 2023 | $287.23K |
| Current Assets | Q1 2024 · Nov 30, 2023 | $5.87M |
| Current Assets | Q1 2024 · Aug 31, 2023 | $6.3M |
| Total Assets | Q1 2024 · Nov 30, 2023 | $7.18M |
| Total Assets | Q1 2024 · Aug 31, 2023 | $7.62M |
| Shares Diluted | Q1 2024 · Nov 30, 2022 | 53.2M sh |
| Operating Cash Flow | Q1 2024 · Nov 30, 2022 | −$469.45K |
| Stockholders Equity | Q1 2024 · Nov 30, 2022 | $8.93M |
| Stockholders Equity | Q1 2024 · Aug 31, 2022 | $9.57M |
| Eps Diluted | Q1 2024 · Nov 30, 2022 | −$0.01 |
| Eps Basic | Q1 2024 · Nov 30, 2022 | −$0.01 |
| Sga Expense restated | Q1 2024 · Nov 30, 2022 | $384.48K |
| Rd Expense restated | Q1 2024 · Nov 30, 2022 | $216.57K |
| Net Income | Q1 2024 · Nov 30, 2022 | −$726.16K |
| Operating Income restated | Q1 2024 · Nov 30, 2022 | −$601.05K |